<document id="DDI-MedLine.d7">
    <sentence id="DDI-MedLine.d7.s0" text="Enhanced theophylline clearance secondary to phenytoin therapy.&#10;">
        <entity charOffset="9-20" id="DDI-MedLine.d7.s0.e0" text="theophylline" type="drug" />
        <entity charOffset="45-53" id="DDI-MedLine.d7.s0.e1" text="phenytoin" type="drug" />
        <pair ddi="true" e1="DDI-MedLine.d7.s0.e0" e2="DDI-MedLine.d7.s0.e1" id="DDI-MedLine.d7.s0.p0" type="mechanism" />
    </sentence>
    <sentence id="DDI-MedLine.d7.s1" text="This report describes two cases in which theophylline clearance accelerated markedly with concomitant phenytoin administration. ">
        <entity charOffset="41-52" id="DDI-MedLine.d7.s1.e0" text="theophylline" type="drug" />
        <entity charOffset="102-110" id="DDI-MedLine.d7.s1.e1" text="phenytoin" type="drug" />
        <pair ddi="true" e1="DDI-MedLine.d7.s1.e0" e2="DDI-MedLine.d7.s1.e1" id="DDI-MedLine.d7.s1.p0" type="mechanism" />
    </sentence>
    <sentence id="DDI-MedLine.d7.s2" text="Maximum calculated theophylline clearance ranged from 2 1/2 to 3 1/2 times baseline. ">
        <entity charOffset="19-30" id="DDI-MedLine.d7.s2.e0" text="theophylline" type="drug" />
    </sentence>
    <sentence id="DDI-MedLine.d7.s4" text="With combined use, clinicians should be aware, when phenytoin is added, of the potential for reexacerbation of pulmonary symptomatology due to lowered serum theophylline concentrations.">
        <entity charOffset="52-60" id="DDI-MedLine.d7.s4.e0" text="phenytoin" type="drug" />
        <entity charOffset="157-168" id="DDI-MedLine.d7.s4.e1" text="theophylline" type="drug" />
        <pair ddi="true" e1="DDI-MedLine.d7.s4.e0" e2="DDI-MedLine.d7.s4.e1" id="DDI-MedLine.d7.s4.p0" type="effect" />
    </sentence>
</document>